REGISTER RECORD · clinicaltrials.gov
NCT00153101
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
AS THE REGISTER RECORDS IT
Status and dates
| Status as listed | COMPLETED: completed |
|---|---|
| Register last updated | 2014-05-20 |
| Retrieved by this site | 2026-08-31 |
| Source | https://clinicaltrials.gov/study/NCT00153101 |
What this record shows
This entry describes research activity. It is not a statement about market authorisation, and it is not regulatory, legal or medical advice: a trial being listed, completed or halted says nothing about whether a substance may be sold or used anywhere. Status wording is reproduced as the register writes it and is never mapped onto a simpler vocabulary.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.